Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
August-2025 Volume 32 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2025 Volume 32 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Splice‑site variant c.3531+1G>T in COL1A1 in a family with osteogenesis imperfecta

  • Authors:
    • Yanru Huang
    • Yixi Zhou
    • Lutan Zhang
    • Ye Shen
    • Xingmei Yao
    • Jieqiong Xie
    • Libin Mei
    • Yunsheng Ge
  • View Affiliations / Copyright

    Affiliations: Department of Central Laboratory, Fujian Key Clinical Specialty of Laboratory Medicine, Department of Obstetrics and Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian 361003, P.R. China, Department of Central Laboratory, Fujian Key Clinical Specialty of Laboratory Medicine, Department of Obstetrics and Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian 361003, P.R. China, Department of Reproductive Medicine, Department of Obstetrics and Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian 361003, P.R. China
    Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 217
    |
    Published online on: May 28, 2025
       https://doi.org/10.3892/mmr.2025.13582
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Osteogenesis imperfecta (OI) is a connective tissue disorder characterized by high genetic and phenotypic heterogeneity. Notably, 90% of cases of OI are caused by pathogenic variants in the COL1A1 and COL1A2 genes, with those in COL1A1 being the most common. The present study aimed to investigate the genetic etiology of OI in a family and the pathogenicity of the splice‑site variant. Whole‑exome sequencing was performed for the proband and Sanger sequencing was performed for all family members to validate the results. Reverse transcription (RT)‑PCR on lymphocyte strains was performed on the proband and an age‑matched control, and minigene experiments were performed to verify the splicing patterns. A heterozygous variant, c.3531+1G>T, was detected in COL1A1 in all patients in the family. RT‑PCR showed an increase in abnormal transcript expression and a decrease in normal transcript expression in the proband. Minigene splicing assays revealed that the mutant gene exhibited four splicing patterns, whereas the normal gene exhibited three splicing patterns. This finding indicated that the c.3531+1G>T variant site affected intron 47 splicing. To the best of our knowledge, this variant was first reported in the Palestinian population, whereas the present study is the first to report this variant in the Chinese population and to clarify the effect of this variant. The results expand the spectrum of pathogenic variants associated with OI.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Uttarilli A, Shah H, Bhavani GS, Upadhyai P, Shukla A and Girisha KM: Phenotyping and genotyping of skeletal dysplasias: Evolution of a center and a decade of experience in India. Bone. 120:204–211. 2019. View Article : Google Scholar : PubMed/NCBI

2 

Nicol L, Morar P, Wang Y, Henriksen K, Sun S, Karsdal M, Smith R, Nagamani SCS, Shapiro J, Lee B and Orwoll E: Alterations in non-type I collagen biomarkers in osteogenesis imperfecta. Bone. 120:70–74. 2019. View Article : Google Scholar : PubMed/NCBI

3 

Forlino A, Cabral WA, Barnes AM and Marini JC: New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol. 7:540–557. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Ablin DS: Osteogenesis imperfecta: A review. Can Assoc Radiol J. 49:110–123. 1998.PubMed/NCBI

5 

Marini JC, Forlino A, Bächinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D, et al: Osteogenesis imperfecta. Nat Rev Dis Primers. 3:170522017. View Article : Google Scholar : PubMed/NCBI

6 

Li L, Mao B, Li S, Xiao J, Wang H, Zhang J, Ren X, Wang Y, Wu Y, Cao Y, et al: Genotypic and phenotypic characterization of Chinese patients with osteogenesis imperfecta. Hum Mutat. 40:588–600. 2019.PubMed/NCBI

7 

Tromp G, Kuivaniemi H, Stacey A, Shikata H, Baldwin CT, Jaenisch R and Prockop DJ: Structure of a full-length cDNA clone for the prepro alpha 1(I) chain of human type I procollagen. Biochem J. 253:919–922. 1988. View Article : Google Scholar : PubMed/NCBI

8 

Essawi O, Symoens S, Fannana M, Darwish M, Farraj M, Willaert A, Essawi T, Callewaert B, De Paepe A, Malfait F and Coucke PJ: Genetic analysis of osteogenesis imperfecta in the Palestinian population: Molecular screening of 49 affected families. Mol Genet Genomic Med. 6:15–26. 2018. View Article : Google Scholar : PubMed/NCBI

9 

Plagnol V, Curtis J, Epstein M, Mok KY, Stebbings E, Grigoriadou S, Wood NW, Hambleton S, Burns SO, Thrasher AJ, et al: A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics. 28:2747–2754. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al: ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 17:405–424. 2015. View Article : Google Scholar : PubMed/NCBI

11 

Biesecker LG and Harrison SM: ClinGen sequence variant interpretation working group. The ACMG/AMP reputable source criteria for the interpretation of sequence variants. Genet Med. 20:1687–1688. 2018. View Article : Google Scholar : PubMed/NCBI

12 

Abou Tayoun AN, Pesaran T, DiStefano MT, Oza A, Rehm HL, Biesecker LG and Harrison SM: ClinGen sequence variant interpretation working group (ClinGen SVI). Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum Mutat. 39:1517–1524. 2018. View Article : Google Scholar : PubMed/NCBI

13 

Wang Z, Zhao G, Zhu Z, Wang Y, Xiang X, Zhang S, Luo T, Zhou Q, Qiu J, Tang B, et al: VarCards2: An integrated genetic and clinical database for ACMG-AMP variant-interpretation guidelines in the human whole genome. Nucleic Acids Res. 52:D1478–D1489. 2024. View Article : Google Scholar : PubMed/NCBI

14 

Neitzel H: A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet. 73:320–326. 1986. View Article : Google Scholar : PubMed/NCBI

15 

Van Dijk FS, Semler O, Etich J, Köhler A, Jimenez-Estrada JA, Bravenboer N, Claeys L, Riesebos E, Gegic S, Piersma SR, et al: Interaction between KDELR2 and HSP47 as a key determinant in osteogenesis imperfecta caused by bi-allelic variants in KDELR2. Am J Hum Genet. 107:989–999. 2020. View Article : Google Scholar : PubMed/NCBI

16 

Tuysuz B, Uludag Alkaya D, Geyik F, Alaylıoğlu M, Kasap B, Kurugoğlu S, Akman YE, Vural M and Bilguvar K: Biallelic frameshift variants in PHLDB1 cause mild-type osteogenesis imperfecta with regressive spondylometaphyseal changes. J Med Genet. 60:819–826. 2023. View Article : Google Scholar : PubMed/NCBI

17 

Umair M, Hassan A, Jan A, Ahmad F, Imran M, Samman MI, Basit S and Ahmad W: Homozygous sequence variants in the FKBP10 gene underlie osteogenesis imperfecta in consanguineous families. J Hum Genet. 61:207–213. 2016. View Article : Google Scholar : PubMed/NCBI

18 

Umair M, Alhaddad B, Rafique A, Jan A, Haack TB, Graf E, Ullah A, Ahmad F, Strom TM, Meitinger T and Ahmad W: Exome sequencing reveals a novel homozygous splice site variant in the WNT1 gene underlying osteogenesis imperfecta type 3. Pediatr Res. 82:753–758. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Hayat A, Hussain S, Bilal M, Kausar M, Almuzzaini B, Abbas S, Tanveer A, Khan A, Siddiqi S, Foo JN, et al: Biallelic variants in four genes underlying recessive osteogenesis imperfecta. Eur J Med Genet. 63:1039542020. View Article : Google Scholar : PubMed/NCBI

20 

Rauch F and Glorieux FH: Osteogenesis imperfecta. Lancet. 363:1377–1385. 2004. View Article : Google Scholar : PubMed/NCBI

21 

Malfait F, Symoens S, De Backer J, Hermanns-Lê T, Sakalihasan N, Lapière CM, Coucke P and De Paepe A: Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood. Hum Mutat. 28:387–395. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Jovanovic M, Guterman-Ram G and Marini JC: Osteogenesis imperfecta: Mechanisms and signaling pathways connecting classical and rare OI types. Endocr Rev. 43:61–90. 2022. View Article : Google Scholar : PubMed/NCBI

23 

Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, Hyland JC, Körkkö J, Prockop DJ, De Paepe A, et al: Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: Regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat. 28:209–221. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Wei S, Yao Y, Shu M, Gao L, Zhao J, Li T, Wang Y and Xu C: Genotype-phenotype relationship and follow-up analysis of a Chinese cohort with osteogenesis imperfecta. Endocr Pract. 28:760–766. 2022. View Article : Google Scholar : PubMed/NCBI

25 

Aliyeva L, Ongen YD, Eren E, Sarisozen MB, Alemdar A, Temel SG and Sag SO: Genotype and phenotype correlation of patients with osteogenesis imperfecta. J Mol Diagn. 26:754–769. 2024. View Article : Google Scholar : PubMed/NCBI

26 

Willing MC, Deschenes SP, Scott DA, Byers PH, Slayton RL, Pitts SH, Arikat H and Roberts EJ: Osteogenesis imperfecta type I: Molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet. 55:638–647. 1994.PubMed/NCBI

27 

Vandersteen AM, Lund AM, Ferguson DJ, Sawle P, Pollitt RC, Holder SE, Wakeling E, Moat N and Pope FM: Four patients with Sillence type I osteogenesis imperfecta and mild bone fragility, complicated by left ventricular cardiac valvular disease and cardiac tissue fragility caused by type I collagen mutations. Am J Med Genet A. 164A:386–391. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Malmgren B, Andersson K, Lindahl K, Kindmark A, Grigelioniene G, Zachariadis V, Dahllöf G and Åström E: Tooth agenesis in osteogenesis imperfecta related to mutations in the collagen type I genes. Oral Dis. 23:42–49. 2017. View Article : Google Scholar : PubMed/NCBI

29 

Van Dijk FS: Genetics of osteoporosis in children. Endocr Dev. 28:196–209. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Swinnen FK, Coucke PJ, De Paepe AM, Symoens S, Malfait F, Gentile FV, Sangiorgi L, D'Eufemia P, Celli M, Garretsen TJ, et al: Osteogenesis imperfecta: The audiological phenotype lacks correlation with the genotype. Orphanet J Rare Dis. 6:882011. View Article : Google Scholar : PubMed/NCBI

31 

Byers PH, Duvic M, Atkinson M, Robinow M, Smith LT, Krane SM, Greally MT, Ludman M, Matalon R, Pauker S, et al: Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen. Am J Med Genet. 72:94–105. 1997. View Article : Google Scholar : PubMed/NCBI

32 

Körkkö J, Ala-Kokko L, De Paepe A, Nuytinck L, Earley J and Prockop DJ: Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: Identification of common sequences of null-allele mutations. Am J Hum Genet. 62:98–110. 1998. View Article : Google Scholar : PubMed/NCBI

33 

Baralle D and Baralle M: Splicing in action: Assessing disease causing sequence changes. J Med Genet. 42:737–748. 2005. View Article : Google Scholar : PubMed/NCBI

34 

Bardai G, Moffatt P, Glorieux FH and Rauch F: DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: Diagnostic yield and mutation spectrum. Osteoporos Int. 27:3607–3613. 2016. View Article : Google Scholar : PubMed/NCBI

35 

Stover ML, Primorac D, Liu SC, McKinstry MB and Rowe DW: Defective splicing of mRNA from one COL1A1 allele of type I collagen in nondeforming (type I) osteogenesis imperfecta. J Clin Invest. 92:1994–2002. 1993. View Article : Google Scholar : PubMed/NCBI

36 

Ito K, Patel PN, Gorham JM, McDonough B, DePalma SR, Adler EE, Lam L, MacRae CA, Mohiuddin SM, Fatkin D, et al: Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing. Proc Natl Acad Sci USA. 114:7689–7694. 2017. View Article : Google Scholar : PubMed/NCBI

37 

Dong Z, Wang Y, Zhang J, Zhu F, Liu Z, Kang Y, Lin M and Shi H: Analyzing the effects of BRCA1/2 variants on mRNA splicing by minigene assay. J Hum Genet. 68:65–71. 2023. View Article : Google Scholar : PubMed/NCBI

38 

Yang Y, Luo H, Pan L, Feng C, Guo Z, Zou Y, Zeng B, Huang S, Yuan H, Wu P, et al: Reevaluating the splice-altering variant in TECTA as a cause of nonsyndromic hearing loss DFNA8/12 by functional analysis of RNA. Hum Mol Genet. Apr 27–2024.(Epub ahead of print). View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Huang Y, Zhou Y, Zhang L, Shen Y, Yao X, Xie J, Mei L and Ge Y: Splice‑site variant c.3531+1G&gt;T in <em>COL1A1</em> in a family with osteogenesis imperfecta. Mol Med Rep 32: 217, 2025.
APA
Huang, Y., Zhou, Y., Zhang, L., Shen, Y., Yao, X., Xie, J. ... Ge, Y. (2025). Splice‑site variant c.3531+1G&gt;T in <em>COL1A1</em> in a family with osteogenesis imperfecta. Molecular Medicine Reports, 32, 217. https://doi.org/10.3892/mmr.2025.13582
MLA
Huang, Y., Zhou, Y., Zhang, L., Shen, Y., Yao, X., Xie, J., Mei, L., Ge, Y."Splice‑site variant c.3531+1G&gt;T in <em>COL1A1</em> in a family with osteogenesis imperfecta". Molecular Medicine Reports 32.2 (2025): 217.
Chicago
Huang, Y., Zhou, Y., Zhang, L., Shen, Y., Yao, X., Xie, J., Mei, L., Ge, Y."Splice‑site variant c.3531+1G&gt;T in <em>COL1A1</em> in a family with osteogenesis imperfecta". Molecular Medicine Reports 32, no. 2 (2025): 217. https://doi.org/10.3892/mmr.2025.13582
Copy and paste a formatted citation
x
Spandidos Publications style
Huang Y, Zhou Y, Zhang L, Shen Y, Yao X, Xie J, Mei L and Ge Y: Splice‑site variant c.3531+1G&gt;T in <em>COL1A1</em> in a family with osteogenesis imperfecta. Mol Med Rep 32: 217, 2025.
APA
Huang, Y., Zhou, Y., Zhang, L., Shen, Y., Yao, X., Xie, J. ... Ge, Y. (2025). Splice‑site variant c.3531+1G&gt;T in <em>COL1A1</em> in a family with osteogenesis imperfecta. Molecular Medicine Reports, 32, 217. https://doi.org/10.3892/mmr.2025.13582
MLA
Huang, Y., Zhou, Y., Zhang, L., Shen, Y., Yao, X., Xie, J., Mei, L., Ge, Y."Splice‑site variant c.3531+1G&gt;T in <em>COL1A1</em> in a family with osteogenesis imperfecta". Molecular Medicine Reports 32.2 (2025): 217.
Chicago
Huang, Y., Zhou, Y., Zhang, L., Shen, Y., Yao, X., Xie, J., Mei, L., Ge, Y."Splice‑site variant c.3531+1G&gt;T in <em>COL1A1</em> in a family with osteogenesis imperfecta". Molecular Medicine Reports 32, no. 2 (2025): 217. https://doi.org/10.3892/mmr.2025.13582
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team